New cyclic arylguanidine scaffolds as a platform for development of antimicrobial and antiviral agents

According to WHO, infectious diseases are still a significant threat to public health. The combine effects of antibiotic resistance, immunopressure, and mutations within the bacterial and viral genomes necessitates the search for new molecules exhibiting antimicrobial and antiviral activities. Such molecules often contain cyclic guanidine moiety. As part of this work, we investigated the selected antimicrobial and antiviral activity of compounds from the cyclic arylguanidine group. Molecules were designed using molecular modeling and ob-tained using microwave radiation (MW) and sonochemical ()))) methods, in accordance with the previously developed pathways. The obtained compounds were screened for the ability to inhibit the growth of Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans, and Cryptococcus neoformans. The capacity to block the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the host cell was probed using a bioluminescence immunoassay. The cytotoxicity and hemolytic properties of the most active molecules were also evaluated. The N-[2-(naphthalen-1-yl)ethyl]-5-phenyl-1,4,5,6-tetrahydro-1,3,5-triazin-2-amine 12j showed a high inhibition of Staphylococcus aureus and Cryptococcus neoformans (MIC & LE; 0.25 & mu;g/mL), with no cytotoxic nor hemolytic effect (CC50, HC10 > 32 & mu;m/mL). The CO-ADD platform identified many potentially useful molecules. A particularly rich population was examined in the database of the N.D. Zelinsky Institute of Organic Chemistry, in which 2517 active molecules (MIC & LE; 32 mg/mL) were found, of which about 10% are active at very low concentrations (MIC & LE; 1 mg/mL).

Automated summary

According to the World Health Organization, infectious diseases continue to pose a significant threat to public health. Due to factors such as antibiotic resistance, immunopressure, and genetic mutations, there is a need to search for new molecules with antimicrobial and antiviral activities. This study investigated the antimicrobial and antiviral properties of compounds from the cyclic arylguanidine group, with promising results.